1Hoist JJ. The physiology of glueagon - like peptide 1 [ J]. Physiol Rev, 2007,87(4) :1409 - 1439.
2Anini Y, Hanaotia T, Brubaker PL. Muscarinie receptors control postprandial release of glucagon - like peptide - 1 : in vivo and in vitro studies in rats [ J ]. Endocrinology ,2002,143 (6) :2420 - 2426.
6Kieffer TJ, Habener JF. The glueagon like peptide[ J]. Endoer Rev, 1999, 20(6) :876-913.
7Holst JJ, Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans[ J]. Am J Physiol Endocrinol Metab, 2004, 287(2):E199-206.
8Deacon CF. Therapeutic strategies based on glucagon -like peptide 1 [J]. Diabetes, 2004,53(9) :2181 -2189. Review.
10Bulotta A, Hui H, Anastasi E, et al. Cultured pancreatic ductal cells undergo cell cycle re - distribution and beta - cell - like differentiation in response to glucagon -like peptide -1 [ J]. J Mol Endocrinol, 2002,29(3) :347-360.
6Wang X,Zhou J,Doyle ME,et al.Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.Endocrinology,2001,142:1820-1827.
7Buteau J,Roduit R,Susini S.Glucagon-like peptide-1 promotes DNA synthesis,activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1)DNA binding activity in beta (INS-1)-cells.Diabetologia,1999,42:856-864.
8Perfetti R, Merkel P. Glucagon-like peptide-1: a major regulator of pancreatic β-cell function. Eur J Endocrinol, 2000,143:717-725.
9Drucker DJ. Minireview: The glucagon-like peptides. Endocrinology,2001,143:521-527.
10Fehmann HC, Habener JF. Insulinotropic hormone glucagon-like peptide-1 (7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma β TC-1 cells. Endocrinology, 1992,130:159-166.
